Skip to main content

Table 1 Demographic, surgical, pathological and postoperative data from 413 patients undergoing pancreatic resection for pancreatic ductal adenocarcinoma (1994–2014)

From: The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma

 

Pancreaticoduodenectomy

Distal pancreatectomy

p

N of resections

347

66

 

Gender

  

0.755

 Male

182 [52 %]

36 [55 %]

 Female

165 [48 %]

30 [45 %]

Age in years median (range)

67.0 (31–89)

65.6 (35–88)

0.362

BMI in kg/m2 median (range)

24.4 (7.6–38.8)

23.6 (18.2–35.4)

0.725

Operation time in min median (range)

440 (245–760)

301 (140–717)

<0.001

PRBC received

if received, vol. in ml mean (±SD)

135 [39 %]

17 [27 %]

0.056

423 (±729)

192 (±368)

0.024

Extended resection

   

 - none

204 [59 %]

38 [58 %]

<0.001

 - portal vein

128 [37 %]

9 [14 %]

 - multivisceral

15 [4 %]

19 [29 %]

Free resection margin

247 [71 %]

46 [73 %]

0.767

Gradinga

   

 G1

11 [3 %]

5 [9 %]

0.229

 G2

194 [57 %]

28 [51 %]

 G3

128 [38 %]

21 [38 %]

 G4

6 [2 %]

1 [2 %]

Tumor size in mm median (range)

28 (1–130)

38 (5–110)

<0.001

Node positive

246 [71 %]

35 [57 %]

0.030

N of analyzed nodes median (range)

15 (2–47)

15 (2–32)

0.783

Any complication

181 [52 %]

32 [49 %]

0.584

Surgical complication

123 [35 %]

20 [30 %]

0.421

 - POPF

48 [14 %]

25 [38 %]

<0.001

 - IAA

25 [7 %]

8 [12 %]

0.177

 - SSI

44 [13 %]

6 [9 %]

0.413

Re-operation

33 [10 %]

10 [15 %]

0.169

Mortality

7 [2 %]

2 [3 %]

0.605

Adjuvant/additive chemotherapy

188 [54 %]

35 [53 %]

0.864

  1. BMI body mass index, PRBC packed red blood cells, POPF postoperative pancreatic fistula, IAA intraabdominal abscess, SSI surgical site infection
  2. aData for Tumor grading was not available for 19 patients (PD: 8 patients; DP: 11 patients)